Miraj Patel
About Miraj Patel
Miraj Patel is the Director of Worldwide Health Economics & Outcomes Research at Bristol Myers Squibb, with extensive experience in oncology and a background in academia and various roles at Sanofi and LEO Pharma.
Company
Miraj Patel is currently employed at Bristol Myers Squibb, where he serves as the Director of Worldwide Health Economics & Outcomes Research. In this role, he has been focused primarily on oncology health economics and outcomes research, particularly for bladder, prostate, and renal cell carcinoma (RCC) since November 2022.
Title
Miraj Patel holds the title of Director, Worldwide Health Economics & Outcomes Research at Bristol Myers Squibb. He has significant experience in health economics, value assessment, and outcomes research, particularly in the field of oncology.
Education and Expertise
Miraj Patel has a strong educational background in health sciences. He earned his Doctor of Pharmacy degree from the University of Maryland Eastern Shore School of Pharmacy. He also holds a Master of Science degree in Health Outcomes, Policy, and Economics from the Rutgers School of Public Health. Additionally, he achieved a Bachelor of Science degree in Physiology & Neurobiology from the University of Maryland. Patel has extensive expertise in health economics and outcomes research, particularly in oncology.
Background
Miraj Patel has a diverse professional background in health economics and outcomes research. Prior to his current role at Bristol Myers Squibb, he worked at LEO Pharma as Director of Health Economics & Outcomes Research from 2020 to 2022 in Madison, New Jersey. He also served at Sanofi in various capacities, including Director, Associate Director, and Manager of Health Economics & Value Assessment from 2015 to 2020. During his tenure at Sanofi, he completed a Postdoctoral Fellowship in Health Economics & Outcomes Research. Additionally, Patel worked as an Adjunct Lecturer at the University of Maryland Eastern Shore from 2018 to 2022, contributing to the academic field.
Achievements
Miraj Patel has led several initiatives in oncology health economics and outcomes research. At Bristol Myers Squibb, he has focused on bladder, prostate, and renal cell carcinoma (RCC) since November 2022. Previously, he was responsible for leading health economics and outcomes research for bladder and prostate cancers at the same company from January to November 2022. His work has contributed to the academic and practical advancements in health economics, particularly in the field of oncology.